Abstract
Background: Hidradenitis suppurativa (HS) affects different patient populations that require unique considerations in their management. However, no HS guidelines for these populations exist. Objective: To provide evidence-based consensus recommendations for patients with HS in 7 special patient populations: (i) pregnancy, (ii) breastfeeding, (iii) pediatrics, (iv) malignancy, (v) tuberculosis infection, (vi) hepatitis B or C infection, and (vii) HIV disease. Methods: Recommendations were developed using the Grading of Recommendations Assessment, Development, and Evaluation system to ascertain level of evidence and selected through a modified Delphi consensus process. Results: One hundred eighteen expert consensus statements are provided for the management of patients with HS across these 7 special patient populations.
| Original language | English (US) |
|---|---|
| Pages (from-to) | 825-852 |
| Number of pages | 28 |
| Journal | Journal of the American Academy of Dermatology |
| Volume | 92 |
| Issue number | 4 |
| DOIs | |
| State | Published - Apr 2025 |
Bibliographical note
Publisher Copyright:© 2025 American Academy of Dermatology, Inc.
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
Keywords
- HIV
- North America
- antiandrogens
- antibiotics
- biologics
- breastfeeding
- comorbidity
- guidelines
- hepatitis B
- hepatitis C
- hidradenitis suppurativa
- immunomodulators
- immunosuppressive
- malignancy
- management
- pediatric
- pregnancy
- safety
- therapy
- tuberculosis
Fingerprint
Dive into the research topics of 'North American clinical practice guidelines for the medical management of hidradenitis suppurativa in special patient populations'. Together they form a unique fingerprint.Cite this
- APA
- Standard
- Harvard
- Vancouver
- Author
- BIBTEX
- RIS